Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity
01:39pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.
LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity
10:50am, Thursday, 07'th Jul 2022
Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
04:25pm, Monday, 04'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
02:00pm, Monday, 04'th Jul 2022
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
5 ‘Strong Buy' BofA Securities Value 10 Stocks With Very Dependable Dividends
07:19am, Tuesday, 28'th Jun 2022
For years, analysts and portfolio managers have anticipated the return of value stocks as the market moved higher.
LabCorp (LH) Partners HealthVerity to Grow in Drug Development
01:47pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
According to LabCorp (LH), this partnership is expected to broaden its comprehensive, end-to-end drug development and clinical trial programs.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
04:11pm, Tuesday, 21'st Jun 2022 Zacks Investment Research
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
01:27pm, Tuesday, 21'st Jun 2022
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
Quest Diagnostic Stock is Ready to Move Higher
05:00am, Tuesday, 21'st Jun 2022
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been performing relatively stronger than the benchmark indices down only (-20%) on the year.
LabCorp (LH) Gets FDA Nod for VirSeq SARS-CoV-2 NGS Test
04:06pm, Monday, 20'th Jun 2022 Zacks Investment Research
LabCorp's (LH) VirSeq SARS-CoV-2 NGS Test can detect specific SARS-CoV-2 strains to help health care providers make appropriate patient treatment decisions.
Strength Seen in LabCorp (LH): Can Its 3.7% Jump Turn into More Strength?
12:03pm, Monday, 20'th Jun 2022 Zacks Investment Research
LabCorp (LH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Strength Seen in LabCorp (LH): Can Its 3.7% Jump Turn into More Strength?
09:20am, Monday, 20'th Jun 2022
LabCorp (LH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LabCorp (LH) Rides on Innovations Amid Cost Constraints
01:30pm, Monday, 13'th Jun 2022 Zacks Investment Research
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
04:49am, Monday, 06'th Jun 2022 Seeking Alpha
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.
Laboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share
04:07am, Sunday, 05'th Jun 2022
Laboratory Corporation of America's defensible cash production separates it from peers in the current macro-climate. Shares have traded down in recent times, and we feel the company's bottom line fund
